Patents by Inventor Guy Bodson

Guy Bodson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070142400
    Abstract: The invention provides a method for the treatment of allergic conditions by administering to a patient an effective amount of dextrorotatory dihydrochloride of 2-[2-[4-[(4-chloro-phenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid. The treatment is conducted in the absence of levorotatory dihydrochloride of 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid.
    Type: Application
    Filed: January 11, 2007
    Publication date: June 21, 2007
    Inventors: Eric Cossement, Guy Bodson, Jean Gobert
  • Publication number: 20060252934
    Abstract: Levorotatory and dextrorotatory enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine of the formula their preparation and use for the preparation of substantially optically pure enantiomers of 1-[(4-chlorophenyl)phenylmethyl]piperazine, which are themselves valuable intermediate products for the preparation of optically active therapeutic compounds having a very high degree of optical purity.
    Type: Application
    Filed: July 17, 2006
    Publication date: November 9, 2006
    Inventors: Eric Cossement, Guy Bodson, Jean Gobert
  • Publication number: 20060229319
    Abstract: A method is disclosed for the treatment of an allergic condition associated with a cutaneous reaction induced by histamine. There is administered to a patient in need of such treatment the levorotatory dihydrochloride of 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy] acetic acid.
    Type: Application
    Filed: June 16, 2006
    Publication date: October 12, 2006
    Inventors: Eric Cossement, Guy Bodson, Jean Gobert
  • Publication number: 20050182069
    Abstract: Levorotatory and dextrorotatory enantiomers of 1-[(4-chlorophenyl)phenylmethyl)-4-[(4-methylphenyl)sulfonyl]piperazine of the formula their preparation and use for the preparation of substantially optically pure enantiomers of 1-1(4-chlorophenyl)phenylmethyl]piperazine, which are themselves valuable intermediate products for the preparation of optically active therapeutic compounds having a very high degree of optical purity.
    Type: Application
    Filed: April 15, 2005
    Publication date: August 18, 2005
    Inventors: Eric Cossement, Guy Bodson, Jean Gobert
  • Publication number: 20050176732
    Abstract: Levorotatory and dextrorotatory enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine of the formula their preparation and use for the preparation of substantially optically pure enantiomers of 1-[(4-chlorophenyl)phenylmethyl]piperazine, which are themselves valuable intermediate products for the preparation of optically active therapeutic compounds having a very high degree of optical purity.
    Type: Application
    Filed: April 15, 2005
    Publication date: August 11, 2005
    Inventors: Eric Cossement, Guy Bodson, Jean Gobert
  • Publication number: 20040122023
    Abstract: Levorotatory and dextrorotatory enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine of the formula 1
    Type: Application
    Filed: December 2, 2003
    Publication date: June 24, 2004
    Inventors: Eric Cossement, Guy Bodson, Jean Gobert
  • Publication number: 20040122021
    Abstract: Levorotatory and dextrorotatory enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine of the formula 1
    Type: Application
    Filed: December 2, 2003
    Publication date: June 24, 2004
    Inventors: Eric Cossement, Guy Bodson, Jean Gobert
  • Publication number: 20040072825
    Abstract: The present invention relates to the compound 2-(2-(4-((2R)-2-methyl-3-(10H-phenothiazin-10-yl)propyl)-1-piperazinyl)ethoxy)ethanol, and its pharmaceutically acceptable salts, as well as to processes for the preparation thereof. It also relates to pharmaceutical compositions containing the said compounds, as well as to therapeutic uses thereof.
    Type: Application
    Filed: November 5, 2003
    Publication date: April 15, 2004
    Inventors: Yves Lamberty, Jacques Timmermans, Tony Waegemans, Guy Bodson, Febienne Broeders
  • Publication number: 20030204089
    Abstract: Levorotatory and dextrorotatory enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine of the formula 1
    Type: Application
    Filed: March 12, 2003
    Publication date: October 30, 2003
    Inventors: Eric Cossement, Guy Bodson, Jean Gobert
  • Publication number: 20030105112
    Abstract: Levorotatory and dextrorotatory enantiomers of 1-[(4-chlorophenyl)phenylmethyl)-4-](4-methylphenyl)sulfonyl]piperazine of the formula 1
    Type: Application
    Filed: May 10, 2002
    Publication date: June 5, 2003
    Inventors: Eric Cossement, Guy Bodson, Jean Gobert
  • Publication number: 20030105113
    Abstract: Levorotatory and dextrorotatory enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine of the formula 1
    Type: Application
    Filed: June 6, 2002
    Publication date: June 5, 2003
    Inventors: Eric Cossement, Guy Bodson, Jean Gobert
  • Patent number: 6436942
    Abstract: Levorotatory and dextrorotatory enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine of the formula their preparation and use for the preparation of substantially optically pure enantiomers of 1-[(4-chlorophenyl)phenylmethyl]piperazine, which are themselves valuable intermediate products for the preparation of optically active therapeutic compounds having a very high degree of optical purity.
    Type: Grant
    Filed: July 19, 1999
    Date of Patent: August 20, 2002
    Assignee: UCB, S.A.
    Inventors: Eric Cossement, Guy Bodson, Jean Gobert
  • Patent number: 6335331
    Abstract: The present invention relates to new pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride, namely, anhydrous 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride and 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride monohydrate. It also relates to processes for the preparation of these pseudopolymorphic forms and to pharmaceutical compositions containing them.
    Type: Grant
    Filed: March 8, 2001
    Date of Patent: January 1, 2002
    Assignee: UCB, S.A.
    Inventors: Monique Berwaer, Guy Bodson, Michel Deleers, Charles Dogimont, Domenico Fanara, Jacques Timmermans
  • Publication number: 20010021712
    Abstract: The present invention relates to new pseudopolymorphic forms of 2-[2-[4-[bis(4- fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride, namely, anhydrous 2-[2-[4-[bis(4-fluorophenyl)methyl]-l-piperazinyl]ethoxy]acetic acid dihydrochloride and 2-[2-[4-[bis(4-fluorophenyl)methyl]-l-piperazinyl]ethoxy]acetic acid dihydrochloride monohydrate. It also relates to processes for the preparation of these pseudopolymorphic forms and to pharmaceutical compositions containing them.
    Type: Application
    Filed: March 8, 2001
    Publication date: September 13, 2001
    Inventors: Monique Berwaer, Guy Bodson, Michel Deleers, Charles Dogimont, Domenico Fanara, Jacques Timmermans
  • Patent number: 6262057
    Abstract: The present invention relates to new pseudopolymorphic forms of 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride, namely, anhydrous 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride and 2-[2-[-bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride monohydrate. It also relates to processes for the preparation of these pseudopolymorphic forms and to pharmaceutical compositions containing them.
    Type: Grant
    Filed: May 23, 2000
    Date of Patent: July 17, 2001
    Assignee: UCB, S.A.
    Inventors: Monique Berwaer, Guy Bodson, Michel Deleers, Charles Dogimont, Domenico Fanara, Jacques Timmermans
  • Patent number: 6255487
    Abstract: The present invention relates to novel substituted [2-(1-piperazinyl)-ethoxy]methyl compounds of formula in which R1 represents a —CONH2, —CN, —COOH, —COOM or —COOR3 group, M being an alkali metal and R3 being an alkyl radical having from 1 to 4 carbon atoms; and R2 represents a hydrogen atom or a group —COR4 or —R5, where R4 is chosen from the groups —OR6 l or —R7, in which R5 represents an alkyl or alkylaryl radical, R6 represents a linear or branched alkyl radical having from 1 to 4 carbon atoms, a haloalkyl, alkylaryl, alkylnitroaryl or alkylhaloaryl radical, and R7 represents a haloalkyl radical, to a process for the preparation of these compounds, and to their use for the preparation of compounds which are themselves valuable intermediates for the preparation of 2-[2-[4[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-acetic acid or 2-[2-[4-[bix(4-fluorophenyl)methyl&rs
    Type: Grant
    Filed: March 21, 2000
    Date of Patent: July 3, 2001
    Assignee: UCB, S.A.
    Inventors: Guy Duchene, Michel Deleers, Guy Bodson, Genevieve Motte, Francoise Lurquin
  • Patent number: 6140501
    Abstract: Novel substituted [2-(1-piperazinyl)ethoxy]methyl compounds.The present invention related to novel substituted [2-(1-piperazinyl)-ethoxy]methyl compounds of formula ##STR1## in which R.sub.1 represents a --CONH.sub.2, --CN, --COOH, --COOM or --COOR.sub.3 group, M being an alkali metal and R.sub.3 being an alkyl radical having from 1 to 4 carbon atoms; andR.sub.2 represents a hydrogen atom or a group --COR.sub.4 or --R.sub.5, where R.sub.4 is chosen from the groups --OR.sub.6 or --R.sub.7, in whichR.sub.5 represents an allyl or alkylaryl radical,R.sub.6 represents a linear or branched alkyl radical having from 1 to 4 carbon atoms, a haloalkyl, alkylaryl, alkylnitroaryl or alkylhaloaryl radical, andR.sub.
    Type: Grant
    Filed: October 9, 1998
    Date of Patent: October 31, 2000
    Assignee: UCB, S.A.
    Inventors: Guy Duchene, Michel Deleers, Guy Bodson, Genevieve Motte, Francoise Lurquin
  • Patent number: 5792770
    Abstract: Levorotatory and dextrorotatory enantiomers of 1-?(4-chlorophenyl)phenylmethyl!-4-?(4-methylphenyl)sulfonyl!piperazine of the formula ##STR1## their preparation and use for the preparation of substantially optically pure enantiomers of 1-?(4-chlorophenyl)phenylmethyl!piperazine, which are themselves valuable intermediate products for the preparation of optically active therapeutic compounds having a very high degree of optical purity.
    Type: Grant
    Filed: October 9, 1997
    Date of Patent: August 11, 1998
    Assignee: U C B S.A.
    Inventors: Eric Cossement, Guy Bodson, Jean Gobert
  • Patent number: 5703082
    Abstract: Levorotatory and dextrorotatory enantiomers of 1-?(4-chlorophenyl)phenylmethyl!-4-?(4-methylphenyl)sulfonyl!piperazine of the formula ##STR1## their preparation and use for the preparation of substantially optically pure enantiomers of 1-?(4-chlorophenyl)phenylmethyl!piperazine, which are themselves valuable intermediate products for the preparation of optically active therapeutic compounds having a very high degree of optical purity.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: December 30, 1997
    Assignee: U C B S.A.
    Inventors: Eric Cossement, Guy Bodson, Jean Gobert
  • Patent number: 5478941
    Abstract: Levorotatory and dextrorotatory enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine of the formula ##STR1## their preparation and use for the preparation of substantially optically pure enantiomers of 1-[(4-chlorophenyl)phenylmethyl]piperazine, which are themselves valuable intermediate products for the preparation of optically active therapeutic compounds having a very high degree of optical purity.
    Type: Grant
    Filed: March 8, 1994
    Date of Patent: December 26, 1995
    Assignee: U C B, S.A.
    Inventors: Eric Cossement, Guy Bodson, Jean Gobert